ALUR
Allurion Technologies, Inc.
NYSE: ALUR · HEALTHCARE · MEDICAL DEVICES
$0.74
-0.03% today
Updated 2026-04-29
Market cap
$8.96M
P/E ratio
—
P/S ratio
0.52x
EPS (TTM)
$-16.20
Dividend yield
—
52W range
$0 – $4
Volume
3.2M
Allurion Technologies, Inc. (ALUR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | $38.24M | $64.21M | $53.47M | $32.11M |
| Revenue growth (YoY) | — | — | +67.9% | -16.7% | -39.9% |
| Cost of revenue | — | $9.05M | $13.48M | $11.97M | $10.61M |
| Gross profit | — | $29.19M | $50.73M | $41.50M | $21.50M |
| Gross margin | — | 76.3% | 79.0% | 77.6% | 67.0% |
| R&D | — | $5.73M | $16.97M | $27.69M | $17.37M |
| SG&A | — | $8.82M | $15.37M | $46.02M | $28.40M |
| Operating income | $-5169.00 | $-12.50M | $-32.01M | $-79.08M | $-50.20M |
| Operating margin | — | -32.7% | -49.9% | -147.9% | -156.3% |
| EBITDA | $201128.00 | $-8.01M | $-32.28M | $-69.03M | $-22.17M |
| EBITDA margin | — | -20.9% | -50.3% | -129.1% | -69.0% |
| EBIT | $-5169.00 | $-8.72M | $-33.17M | $-69.78M | $-23.17M |
| Interest expense | — | $3.67M | $4.43M | $10.57M | $2.26M |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5169.00 | $-12.39M | $-37.74M | $-80.61M | $-26.15M |
| Net income growth (YoY) | — | -239520.8% | -204.7% | -113.6% | +67.6% |
| Profit margin | — | -32.4% | -58.8% | -150.8% | -81.4% |